Effectiveness of pneumococcal polysaccharide vaccine in older adults. - Wikidata - wikimedia - TriplyDB

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

http://www.wikidata.org/entity/Q35118584

about

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia Vaccines for preventing pneumococcal infection in adults Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease Vaccines for preventing pneumococcal infection in adults Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.Measuring diagnoses: ICD code accuracy Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection.Virus-induced secondary bacterial infection: a concise review Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review Chronic obstructive pulmonary disease Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?HIV Infection in the Elderly: Arising Challenges Continuous quality improvement in rural health clinics Respiratory risks from household air pollution in low and middle income countries The role of vaccination in preventing pneumococcal disease in adults Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Suggested use of vaccines in diabetes.Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire.Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults Temporal properties of diagnosis code time series in aggregate.Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.Classification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative data.Pneumococcal Vaccination Strategies. An Update and Perspective.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine National hospitalization trends for pediatric pneumonia and associated complications Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.The burden of community-acquired pneumonia in seniors: results of a population-based study.B1b cells recognize protective antigens after natural infection and vaccination.Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels

P2860

Q23911823-309CAE28-48B4-4B73-912C-6F8BE7620156 Q24201474-F6509EDB-CD8C-4CE5-A5BA-F0CB27B39B9E Q24236699-09476CC7-34C2-4AC8-8FCC-EFA4A9E186E9 Q24242290-478592F2-F842-4EDA-BAB9-53D5D31FDBAA Q24243866-237AF852-F253-4558-896D-24249777A318 Q24532019-F421D220-7C1C-41C6-B877-E4144D9DD47A Q24537540-7552F423-CFD1-4E75-95C2-E8E3AD9A8043 Q24803495-7DD645D5-B20D-41D6-95AD-BEE6F99B415A Q24812252-01F2F801-B49C-4E45-AD3D-BEF76F678282 Q24812332-E30AF5FD-E9EC-4A7F-95F1-AEA3843EF945 Q26783333-E37539F2-75EF-48C3-84F9-45742BE7393D Q27007003-E6B86035-087D-4A20-8807-2A464DAEEDD3 Q27027955-248C04FF-2C39-46D3-8D90-3EAAB2395E36 Q28070059-5A349730-78E7-43FC-AB3E-CE8BB4E94157 Q28076000-C5D630F4-5C48-465D-8196-7A069CFD6076 Q28188813-D982AB32-A3CF-4EEA-80B2-3C81150E0612 Q28391847-7A4E21CF-0063-4AAF-97C8-8DA20FE7A5A5 Q28396749-018EAEFB-2A1B-4465-8EC0-5A6667B60B80 Q30238816-E42B9B3B-BFBF-4FE3-A248-D9D86959AF0B Q30424594-78F4C149-8C4C-4F55-B6FB-D26310F32CEB Q30429085-94D6C09E-8977-4916-BF10-FFCFA216F8F8 Q33225647-11BE5430-A02D-42CD-B377-BC140BC0F67B Q33257998-C683A701-B592-4783-A42E-2E1F8349A7CB Q33303633-10A46654-8380-4900-AA59-68BABD83B9DA Q33312893-3BCCCA1A-BEB0-4EE6-858B-141D665AE1DF Q33360868-F7BF3B2C-D622-44AB-92CD-699C8252A02E Q33542866-A2FBC6C3-F3D4-4152-912B-6026606330BA Q33601853-070B01CC-50A9-44AF-82F1-C0B23C09FE4E Q33647774-678BF76B-5F08-4E82-8A9C-A6A84C3D89F1 Q33712657-577E925D-C7FA-4C9F-A2A8-F15A8804263C Q33719116-1C9B63A1-3560-4108-A63D-BF9E36971D4E Q33750811-45AB4F7F-D9EB-48DC-9BFE-287F2464DF99 Q33772409-4638C196-FF2F-4D0B-AABA-EED1010E9D93 Q33974292-C7A66F1D-CB37-4A14-BBE9-21161F4B6CAE Q34039927-C6F3A881-FFE2-4CB9-9329-602FCA8A76E5 Q34105094-513FB9B8-551B-4892-A000-DE0D31073D93 Q34373295-EAAC0F5E-68A0-4428-B72A-B3C036EE7C90 Q34433081-FC18992C-BB69-4954-A9EC-9CA1F17C4FA5 Q34484101-8E831AF1-302A-4893-A2A2-4EFB762766FF Q34492738-263C09CD-6519-4613-BFA8-60EA375885D9

P2860

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

http://www.wikidata.org/entity/Q35118584

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@ast

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@en

type

label

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@ast

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@en

prefLabel

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@ast

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@en

P1433

Q35118584-7AC164FF-29C9-4F8D-9692-E3CFD0006A93

P1476

Q35118584-321CC4BE-2957-413D-9913-AD2DC87634ED

P2093

Q35118584-105BEA82-CF7B-48B4-84E2-6BA122A307F6

Q35118584-1465C0B9-4704-44C1-9F3F-7ECFE0CB591B

Q35118584-279070B3-020D-4E11-8645-115E13BA76E0

Q35118584-3A8343D9-BCDF-4320-8A0F-1A36A098BD9C

Q35118584-473D690F-8C13-4629-96E4-5EA208E0D8F4

Q35118584-757370D3-3C8D-4993-BD78-D2EAD2EF48EA

Q35118584-79DB3854-312E-4D2C-A0D1-41B1B7D3079B

Q35118584-C406BE7B-9999-4F57-9579-B467415B4D08

Q35118584-D7D7E792-3CBA-42C0-A580-B43573609C4E

Q35118584-D8046D19-CB25-48A4-9923-9E37985B64A0

P304

Q35118584-3F829B3C-7BDD-4FD8-B6C0-235FDE37F681

P31

Q35118584-D05E7815-C21D-4B13-9012-11EBE9EF9DEA

P356

Q35118584-A9B095B4-B20E-432B-AA82-F9EA7F1C6919

P407

Q35118584-DFC812A1-8B9F-45ED-B23C-577ADBD54A98

P433

Q35118584-2BBE8797-1844-4F9F-BEF8-EBE10EC00D2A

P478

Q35118584-30C52CC8-FC7A-4A31-A0B1-21D162E2688D

P50

Q35118584-7694EA6D-CA9A-469F-9A0E-070EAA280DCF

P577

Q35118584-D059FD38-1748-41B9-9BC4-01A69F044FFA

P698

Q35118584-4045E4A2-0530-4558-9EDF-448EBEF75B1C

P921

Q35118584-D105340D-62D1-482C-88B9-97DE71774F44

P356

P1433

The New England Journal of Medicine

P1476

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

@en

P2093

Annette L Adams

http://www.w3.org/2001/XMLSchema#string

Christi A Hanson

http://www.w3.org/2001/XMLSchema#string

Kathleen M Neuzil

http://www.w3.org/2001/XMLSchema#string

Lisa A Jackson

http://www.w3.org/2001/XMLSchema#string

Lisa D Mahoney

http://www.w3.org/2001/XMLSchema#string

Onchee Yu

http://www.w3.org/2001/XMLSchema#string

Patti Benson

http://www.w3.org/2001/XMLSchema#string

Vaccine Safety Datalink

http://www.w3.org/2001/XMLSchema#string

William E Barlow

http://www.w3.org/2001/XMLSchema#string

William W Thompson

http://www.w3.org/2001/XMLSchema#string

P304

1747-1755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA022678

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12724480

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides